Now available across Europe
World Drug Search Services | Europe
We find medicines for you worldwide.
All Europe shipping

Mvasi (bevacizumab) 400 mg/16 mL concentrate for solution for infusion — original (Amgen, USA)

Out of stock
In stock
Qty per pack:
Dosage:
Quantity
+

Out of stock

Get the Best Price
Delivery methods
  • EMC post

Delivery time

  • 7-10 days
Payment methods
  • Payment to Revolut card
Description

Indications for Use

Bevacizumab, a vascular endothelial growth factor (VEGF) inhibitor, is used in several chemotherapy regimens for the treatment of metastatic colorectal cancer; metastatic, unresectable, locally advanced, or recurrent non-squamous non-small cell lung cancer; metastatic renal cell carcinoma; metastatic, persistent, or recurrent cervical cancer; primary peritoneal cancer; epithelial ovarian cancer; fallopian tube cancer; breast cancer; and recurrent glioblastoma.

Specifications
  • Trade Name:
    Mvasi
  • Chemical Name:
    Bevacizumab
  • Dosage:
    400 mg
  • Quantity:
    1 fl.
  • Form of Issue:
    Concentrate
  • Manufacturer:
    Amgen. USA
Reviews
No reviews yet
Write a review
First name*
Email
Write a review*